ClinicalTrials.Veeva

Menu

Hyperbaric Oxygen Therapy as a Neuroprotective Modality in Pediatric Acquired Brain Injury With Motor Disability

K

Kafrelsheikh University

Status

Completed

Conditions

Hyperbaric Oxygen Therapy
Neuroprotective
Acquired Brain Injury
Motor Disability
Pediatric

Treatments

Other: Hyperbaric oxygen therapy
Other: Conventional rehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT06954389
KFSIRB200-137

Details and patient eligibility

About

This study aimed to assess the efficacy of hyperbaric oxygen therapy as a neuroprotective intervention in children with acquired brain injury.

Full description

Pediatric acquired brain injury (ABI) represents a significant challenge in modern medicine, necessitating innovative therapeutic approaches to enhance recovery and minimize long-term neurological deficits.

Hyperbaric oxygen therapy (HBOT), which delivers oxygen at pressures exceeding atmospheric levels, has emerged as a promising neuroprotective intervention for various forms of pediatric brain injury, including traumatic brain injury (TBI), anoxic-ischaemic encephalopathy (AIE), and stroke.

Enrollment

120 patients

Sex

All

Ages

4 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 4-12 years.
  • Diagnosed with pediatric acquired brain injury confirmed by neurological examination and magnetic resonance imaging.
  • Presence of neurological sequelae (e.g., cardiac arrest, intracranial hemorrhage, central nervous system infection, stroke, tumor, hypoxia).

Exclusion criteria

  • Positive family history of degenerative brain insults.

  • Behavioral problems.

  • Contraindications to hyperbaric oxygen therapy :

    • Active epilepsy.
    • Respiratory insufficiency.
    • Uncontrolled heart failure.
    • Eustachian tube dysfunction.
    • Tympanic membrane rupture.
    • Mechanical ventilation dependency.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 2 patient groups

Hyperbaric oxygen therapy group
Experimental group
Description:
Patients received hyperbaric oxygen therapy using a monochamber hyperbaric chamber in addition to conventional rehabilitation.
Treatment:
Other: Hyperbaric oxygen therapy
Control group
Active Comparator group
Description:
Patients received conventional rehabilitation alone.
Treatment:
Other: Conventional rehabilitation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems